Table: RaQualia Pharma - 6-MTH group results

RaQualia Pharma

12/08/2021 07:00

Aug 12 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2021        Jun 30, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.32               372 mln           2.25     
                  (+254.3 pct)         (-31.7 pct)     (+102.9 pct) 
  Operating          314 mln          loss 403 mln        61 mln    
  Recurring          432 mln          loss 402 mln        184 mln   
  Net                302 mln          loss 459 mln        118 mln   
  EPS               14.45 yen        loss 21.93 yen      5.65 yen   
  EPS Diluted       14.45 yen                                       
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T